Frovatriptan succinate hydrate

CAS : 158930-17-7

Ref. TM-T11326

Informations sur le produit

• Nom: Frovatriptan succinate hydrate
• Synonymes: Frovelan, Frova, (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide Butanedioic Acid Monohydrate, Frovatriptan Succinate Monohydrate, Frovelan, Migard, (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide
• CAS: 158930-17-7

Description

Frovatriptan succinate hydrate (Frova) is effective in treating the full spectrum of migraine including the associated symptoms of nausea, vomiting, photophobia, and phonophobia. Frovatriptan succinate hydrate can also be used as in mini-prophylaxis in menstrual migraine. Frovatriptan succinate hydrate is a potent, high affinity, selective and orally active 5-HT1B, HT1D receptor agonist and a moderately potent 5-HT7 receptor agonist, with pKi values of 8.6, 8.4, and 6.7, respectively.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 379.41
• Formule: C₁₈H₂₅N₃O₆
• Degré de pureté: 99.95%
• Couleur/Forme: Solid